WallStreetZenWallStreetZen

NYSEMKT: AIM
Aim Immunotech Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Aim Immunotech earnings were -$15.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AIM earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$3.7M, down 37.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AIM reported annual earnings of -$17.3M, with -40.2% growth.

AIM earnings history

Current Revenue
$146.0k
Current Earnings
-$15.2M
Current Profit Margin
-10,416.4%

AIM Return on Equity

Current Company
-1,586.2%
Current Industry
-60.2%
Current Market
31.4%
AIM's Return on Equity (-1,586.2%)... subscribe to Premium to read more.
High Return on Equity Performance

AIM undefined

Current Company
-137.8%
Current Industry
-2.5%
AIM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AIM announces earnings.

AIM undefined

Current Company
414.07%
Current Industry
5.8%
AIM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AIM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AIM-$13.89M-$15.21MN/A-$24.00
SLXN-$12.28M-$16.16MN/A-$47.32
NLSP-$1.83M-$4.06MN/A-$2.63
INDP-$15.75M-$15.75MN/A-$1.49
GNPX-$19.10M-$19.38MN/A-$2.93
View Top Biotech Stocks

Aim Immunotech Earnings Reports & History FAQ

What were Aim Immunotech's earnings last quarter?

On AIM's earnings call on Invalid Date, Aim Immunotech (NYSEMKT: AIM) reported Q1 2025 earnings per share (EPS) of -$5.00, up 58.33% year over year. Total AIM earnings for the quarter were -$3.71 million. In the same quarter last year, Aim Immunotech's earnings per share (EPS) was -$12.00.

If you're new to stock investing, here's how to buy Aim Immunotech stock.

Is Aim Immunotech profitable or losing money?

As of the last Aim Immunotech earnings report, Aim Immunotech is currently losing money. Aim Immunotech's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$15.21 million, a 51.13% decrease year over year.

What was AIM's earnings growth in the past year?

As of Aim Immunotech's earnings date in Invalid Date, Aim Immunotech's earnings has grown year over year. AIM earnings in the past year totalled -$15.21 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.